News
The FDA has awarded 510(k) clearance to Fujirebio’s Lumipulse G pTau 217/β-Amyloid 1-42 Plasma Ratio in vitro diagnostic (IVD ...
GE HealthCare has gained 501(k) clearance from the US Food and Drug Administration (FDA) for its CleaRecon DL technology.
Ophthalmic technology developer Intalight has received the CE mark for its DREAM OCT (optical coherence tomography) platform ...
Abbott's REFLECT studies indicate that FreeStyle Libre use is linked to a decrease in hospitalisation risk for heart ...
Between 2022 and 2027, leading data and analytics company GlobalData forecasts show cybersecurity spending by healthcare ...
The FDA has granted breakthrough device designation for Elucent Medical’s EnVisio X1 In-Body Spatial Intelligence System.
A new report by Royal Philips warns that the ‘trust gap’ around deploying artificial intelligence (AI) in healthcare systems ...
New research has revealed that UK adults feel "let down" by mental health services provided by the UK's National Health ...
The US Food and Drug Administration (FDA) has granted approval for Roche's VENTANA MET (SP44) RxDx Assay for NSQ-NSCLC.
The German multinational joins the long list of companies boosting US manufacturing to counter Trump’s tariffs.
Health Canada has granted approval to Subtle Medical’s magnetic resonance imaging (MRI) enhancement software, SubtleHD.
Grail has collaborated with athenahealth, aimed at integrating the Galleri MCED test ordering into the athenaCoordinator Core ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results